- 专利标题： COMBINATION THERAPY WITH A HYALURONAN-DEGRADING ENZYME AND AN IMMUNE CHECKPOINT INHIBITOR
-
申请号： US17850903申请日： 2022-06-27
-
公开(公告)号： US20220372151A1公开(公告)日： 2022-11-24
- 发明人: Sanna ROSENGREN , H. Michael SHEPARD , Curtis B. THOMPSON
- 申请人： HALOZYME, INC.
- 申请人地址： US CA San Diego
- 专利权人： HALOZYME, INC.
- 当前专利权人： HALOZYME, INC.
- 当前专利权人地址： US CA San Diego
- 主分类号： C07K16/28
- IPC分类号： C07K16/28 ; A61K38/47 ; A61K31/573 ; A61K39/395 ; A61P35/00 ; C12N9/26 ; C12N15/00 ; A61K47/60
摘要：
Provided are methods of treatment of cancers with combinations of and compositions containing a soluble hyaluronidase, such as a polymer-modified soluble hyaluronidase, and an immune checkpoint inhibitor for treating cancers, including solid and non-solid tumors. The combinations and compositions also are provided.
信息查询
